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B
ioﬁlms on wounds, implants, and in-
dwelling devices generate chronic
and often life-threatening infections
and inﬂammation.1 These persistent infec-
tions can result in tissue damage, device
dysfunction, implant failure, and even
death.2,3 Bioﬁlm infections are notoriously
diﬃcult to treat, as the bioﬁlm matrix pro-
vides physical protection from antibiotic
treatment, which is often enhanced by the
presence of antibiotic-resistant bacteria. Ra-
pid detection and identiﬁcation of bioﬁlms
can provide crucial information for early
diagnosis and eﬀective treatment;4 how-
ever, the identiﬁcation of bacterial species
in bioﬁlms is challenging due to their phy-
siological heterogeneity.5 Conventional bio-
ﬁlm detection methods rely on culturing,
which requires several days for diagnosis
and has low sensitivity.6,7 While molecular
detection methods, such as PCR8 and ﬂuo-
rescence in situ hybridization (FISH),9 have
been developed based on genotyping and
genomic proﬁling, it remains challenging to
rapidly identify bioﬁlms.10
The bioﬁlm matrix accounts for over 90%
of bioﬁlm dry mass, providing a three-
dimensional microenvironment that pro-
tects the bacteria.11 This architecture is
a unique feature that deﬁnes bioﬁlms,
intimately regulating the physical and
functional properties of the bioﬁlm.12 Both
the physical structure of the bioﬁlm and
the composition of the extracellular poly-
meric substances (EPS) in the matrix,
such as polysaccharides, proteins, nucleic
acids, and lipids, vary among bacteria
species.13 For example, polysaccharides
are neutral in Streptococcus,14 polyanionic
in Pseudomonas,15 and polycationic in
Staphylococcus.16 Within a species, the EPS
are even diverse; polysaccharides from vari-
ous strains of Streptococcus thermophilus
feature diﬀerent monomer compositions
and ratios and possess diﬀerent molecular
masses.17
On the basis of the structural and chemical
diﬀerences between bioﬁlms, we hypothe-
sized that an array-based “chemical nose”
approach could be used to detect and diﬀer-
entiate between species and even strains in a
bioﬁlm,1820 potentially minimizing the inter-
ference caused by bioﬁlm heterogeneity11
and phenotypic diversity of bacteria.21,22
Array-based sensing has been used to identify
species and strains of planktonic bacteria.23,24
Optical sensing of bioﬁlms is however amuch
morechallengingprospectdue to thephysical
heterogeneity of the ﬁlms, which introduces
signiﬁcant variability to the sensing process.
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ABSTRACT Identiﬁcation of infectious bacteria responsible for bioﬁlm-associated infections is
challenging due to the complex and heterogeneous bioﬁlm matrix. To address this issue and minimize
the impact of heterogeneity on bioﬁlm identiﬁcation, we developed a gold nanoparticle (AuNP)-based
multichannel sensor to detect and identify bioﬁlms based on their physicochemical properties. Our results
showed that the sensor can discriminate six bacterial bioﬁlms including two composed of uropathogenic bacteria. The capability of the sensor was further
demonstrated through discrimination of bioﬁlms in a mixed bacteria/mammalian cell in vitro wound model.
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Here we report a gold nanoparticle (AuNP)-based
multichannel ﬂuorescence sensor to detect and iden-
tify the species composition of bioﬁlms based on the
overall bioﬁlm physicochemical properties. This sensor
features AuNP-ﬂuorescent protein conjugates that can
be disrupted to give ﬂuorescent readouts in the pre-
sence of bioﬂms (Figure 1), generating an essentially
instantaneous readout. The key feature of this sensor
platform is that it uses a three-color RGB output that
generates a ratiometric response that is less sensitive
to sample variability,25,26 enabling us to completely
diﬀerentiate bacterial species and strains of six bio-
ﬁlms, including two pathogenic clinical isolates, within
minutes. The versatility of this sensor is further demon-
strated by discrimination between two bacterial spe-
cies in a cocultured bioﬁlmﬁbroblast cell wound
model.27
RESULTS AND DISCUSSION
We ﬁrst fabricated two AuNPs (∼2 nm core), one
featuring a cationic hydrophobic (NP1) and the other a
hydrophilic (NP2) functional group (Figure 2A) These
particles were screened from a library of diﬀerent
particles including aromatic and aliphatic headgroups,
ﬁrst to determine the individual particles and then to
optimize their ratio in the sensor. Multichannel output
is provided through reversible adsorption followed
by partial displacement of three ﬂuorescent proteins
with well-separated excitation and emission spectra
(Figure S1): red (tdTomato),28 blue (EBFP2),29 and
green (EGFP).30 These proteins feature negative sur-
face charge, allowing electrostatic interactions with
cationic NP1 and NP2. In the presence of bioﬁlms, the
ﬂuorescently quenched31 AuNPﬂuorescent protein
conjugates are disrupted by the competitive interac-
tions between the negatively charged EPS produced
by the bacterial species and the cationic AuNPs, re-
storing the ﬂuorescence, and hence generate discern-
ing patterns for species recognition in the bioﬁlm
(Figure 1).
In the sensor design, NP1 and NP2 were chosen to
aﬀord selective hydrophobic and hydrophilic interac-
tions with target bioﬁlms. The presence of both NPs
could oﬀer competitive hydrophobic/hydrophilic in-
teractions with bioﬁlm EPS, maximizing bioﬁlm species
composition diﬀerences. We ﬁrst studied the binding
aﬃnities of the ﬂuorescent proteins toward the two
AuNPs by ﬂuorescence titration. In these studies, an
equimolar mixture of the three ﬂuorescent proteins
was titrated with NP1, NP2, and an equimolar mixture
of NP1 and NP2 (Figure 2B and Figure S2). In all cases,
with increasing NP concentrations, ﬂuorescence from
the three proteins was eﬃciently quenched. Nonlinear
curve ﬁtting was used to calculate the NPprotein
complex stability constant (Ks) and association stoichi-
ometry (n) (Table S1). To provide an eﬀective dynamic
range, we chose the point where the NP:ﬂuorescent
protein ratio was 0.8 (160 nM of total AuNPs and
200 nM of each ﬂuorescent protein), generating eﬃ-
cient quenching of all three proteins.
After optimization of particle/protein concentra-
tions, we tested the discriminatory power of our sensor
against six bacterial strains representing ﬁve species
(Amycolatopsis azurea, Bacillus licheniformic, Bacillus
megaterium, Escherichia coli, Pseudomonas aeruginosa),
including one clinical isolate each of uropathogenic
E. coli. and P. aeruginosa. The bacteria were cultured for
3 days in a 96-well microplate in modiﬁed LB media
(see Materials and Methods) at room temperature.32
Bioﬁlmswere observed in each of the culturewells. The
particle/protein sensor solution was then added to
each well and incubated for 45 min before reading.
Figure 2. Schematic illustration of the sensor composition.
(A) Sensor elements and molecular structures of the func-
tional ligands of NP1 and NP2. (B) Fluorescence titration
with an equal molar mixture of NP1 and NP2. Each value is
an average of three data points, and the error bars are
standard deviations.
Figure 1. Schematic illustration of the multichannel sensor.
The sensor is composed of AuNP-ﬂuorescent protein con-
jugates that are disrupted in the presence of bioﬁlms. This
disruption turns on the ﬂuorescence and results in diﬀerent
colored ﬂuorescence patterns for bioﬁlm identiﬁcation.
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As shown in Figure 3A, the six bacterial bioﬁlms
displayed distinct response patterns. The two patho-
genic bacteria, E. coli CD-3 and P. aeruginosa CD-1006,
showed the lowest and the highest responses, respec-
tively, in all three channels, and thus are clearly
distinguished from bioﬁlms formed by the remain-
ing laboratory strains. Interestingly, the bioﬁlms of
B. licheniformis and P. aeruginosa, species known to
form strong bioﬁlms,3335 exhibited higher sensor
responses than bioﬁlms of the other three species,
indicating stronger interactions between the AuNPs
and bioﬁlms.
Quantitative discrimination between the bacterial
strains was obtained using linear discriminant analysis
(LDA).36 According to the jackknifed classiﬁcation ma-
trix in the LDA,37 the six data groups each containing
six points from each bioﬁlm were classiﬁed and
showed 100% separation. The canonical scores of the
ﬁrst two factors were plotted with 95% conﬁdence
ellipses in Figure 3B, showing 100% discrimination
between the bioﬁlms of the six bacterial strains. Com-
parison between individual channels and the three-
channel system (Table S2) indicates that individual
channels were incapable of complete classiﬁcation,
demonstrating the importance of multichannel sensing
in detecting complex analytes such as bioﬁlms. The
bioﬁlm-based clusters did not display Gram-stain-
related separation. This is presumably because the
structural diﬀerences between Gram-positive and
Gram-negative bacteria are located primarily in their
cell walls, whichmay bemasked by the EPS inwhich the
bacteria are embedded.
In addition to clustering, LDA is capable of identify-
ing unknown samples once the system has been
“trained” using a training set of analytes.38 In practice,
four cultures of each of the six bacterial strains were
prepared and labeled randomly to generate a pool of
24 unknown bioﬁlm samples. The sensor identiﬁed 23
out of 24 samples (96%) correctly (see Table S3 for the
detailed identiﬁcation result), simultaneously demon-
strating the diagnostic possibilities of the sensor and
the robustness of the clustering.
Identifying bacterial bioﬁlms on surfaces such as
indwelling devices and implants is a critical capability.
Determination of pathogens in bioﬁlms occurring on
human tissues and organs provides an equally impor-
tant and even more challenging goal. In most cases,
the bacterial pathogens of interest will be embedded
in human tissues within bioﬁlms composed of EPS,
Figure 3. Detection and identiﬁcation of bioﬁlms formedby
four laboratory and two uropathogenic strains of bacteria.
(A) Triple-channel ﬂuorescence response patterns in the
presence of bioﬁlms. I0 is the ﬂuorescence intensity in the
absence of bioﬁlms. Each value is an average of six data
points, and the error bars are standard deviations. (B)
Canonical score plot of the ﬂuorescence response patterns
as obtained by LDA against the six bacterial bioﬁlms.
Figure 4. Detection and identiﬁcation of bioﬁlms grown on
3T3 ﬁbroblast cells. (A) Triple-channel ﬂuorescence re-
sponse patterns in the presence of bioﬁlms grown on
ﬁbroblast cells and 3T3 ﬁbroblast cells alone. I0 is the
ﬂuorescence intensity in the absence of bioﬁlms or 3T3
cells. Each value is an average of six data points, and the
error bars are standard deviations. (B) LDA canonical score
plot of the ﬂuorescence response patterns.
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mammalian cells, and an extracellular matrix. To test
the diagnostic capability of ourmultichannel sensor for
wound bioﬁlms, we employed a bioﬁlmﬁbroblast cell
coculture39,40 as a model. Two bacteria, B. licheniformis
and E. coli DH5R, were chosen as representative Gram-
positive and Gram-negative species. The bacteria were
seededwith a conﬂuent NIH 3T3 (mouse ﬁbroblast) cell
monolayer41 overnight for bioﬁlm formation. The co-
cultures were washed before sensing to remove plank-
tonic bacteria and nonadherent 3T3 cells. The sensor
response patterns for B. licheniformis bioﬁlm-3T3 cells,
E. coli DH5R-bioﬁlm-3T3 cells, and noninfected 3T3
cells were diﬀerent (Figure 4A), with LDA demonstrat-
ing 100% discrimination of the two cocultures and 3T3
cells (Figure 4B). As above, we tested the ability of this
training set to diagnose unknown samples, recogniz-
ing 10 out of 12 samples correctly (see Table S4 for the
detailed identiﬁcation result). These studies indicate
the potential of our system for detection and identiﬁ-
cation of bioﬁlms in infected wounds.
CONCLUSION
In conclusion, we have developed a rapid (minutes)
and eﬀective multichannel sensor for identifying bac-
terial species, and even strains, in bioﬁlms. Using this
AuNP multichannel sensor, we successfully detected
and diﬀerentiated bioﬁlms formed by pathogenic and
nonpathogenic bacteria. These determinations were ef-
fective with bioﬁlms on surfaces and in a bacteria
mammalian cell coculture wound model. The optical
basis of this system is an added beneﬁt, facilitating
translation to both visual42 and camera-based diagnos-
tics.43 Taken together, these capabilities demonstrate the
diagnostic potential of our sensor system, providing a
tool that could enable targeted treatment of bioﬁlm
infections in lieu of broad-spectrum antibiotics.44
MATERIALS AND METHODS
Fluorescent Proteins and Gold Nanoparticles. EBFP2,29 EGFP,45 and
tdTomato28 were expressed in E. coli BL21 (DE3) and purified by
means of Co2þ-affinity chromatography. Cationic NP1 and NP2
(see Supporting Information for synthesis and characterization)
were synthesized as previously reported.46,47
Fluorescence Titration. An equimolar solution of 200 nM
EBFP2, 200 nM EGFP, and 200 nM tdTomato was mixed in
5 mM phosphate buffer (PB, pH = 7.4). The solution with fixed
fluorescent protein concentration was then titrated with NPs at
various concentrations from 0 to 150 nM. For the combination
of NP1 and NP2, NPs were first mixed to make an equimolar
solution, and the NP concentration was defined as the total NP
concentration. After 15 min incubation at room temperature,
the change of fluorescence intensity from three channels was
measured using a Molecular Devices SpectraMax M2 plate
reader. The excitation and emission wavelengths are 380 nm
(ex) and 450 nm (em) for EBFP2; 475 nm (ex) and 510 nm (em)
for EGFP; and 550 nm (ex) and 585 nm (em) for tdTomato.
Nonlinear least-squares curve-fitting analysis by Origin (version
8.0) was employed to estimate the binding constant (Ks) and
association stoichiometry (n), using a model in which the NP is
assumed to possess the n equivalent of independent binding
sites.48
Biofilm Formation in a 96-Well Microplate. Bacteria were inocu-
lated in LB broth at 37 C until stationary phase. The cultures
were then harvested by centrifugation and washed with 0.85%
sodium chloride solution three times. Concentrations of resus-
pended bacterial solution were determined by optical density
measured at 600 nm. LB was supplemented with 0.1% glucose,
1mMMgSO4, 0.15M ammonium sulfate, and 34mM citrate and
buffered to pH 7 to ensure bacterial adherence to the micro-
plate.32 Seeding solutions were then made in this modified
LB to reach an OD600 of 0.1. A 195 μL amount of the seeding
solutions was added to each well of themicroplate. Modified LB
medium without bacteria was used as a negative control. The
plates were covered and incubated at room temperature under
static conditions for 3 days. Fresh media was added on day 2.
Planktonic bacteria were removed before sensing by washing
with PB saline three times.
Sensing of Biofilms in a Microplate. The sensor was composed of
200 nM EBFP2, 200 nM EGFP, 200 nM tdTomato, 80 nMNP1, and
80nmNP2 in5mMPB. The sensorwasmade fresh and incubated
in the dark for 15min before use. It was then added (200 μL) into
each well containing a biofilm and incubated for 45 min. The
fluorescence recovery was monitored using an Optima BMG
Labtech plate reader (see Table S5 for the detailed results).
Biofilm3T3 Fibroblast Cell Coculture. A total of 20 000 NIH 3T3
(ATCC CRL-1658) cells were cultured in Dulbecco's modified
Eagle medium (DMEM; ATCC 30-2002) with 10% bovine calf
serum and 1%antibiotics at 37 C in a humidified atmosphere of
5%CO2. Cells were kept for 48 h to reach a confluentmonolayer.
Bacteria were inoculated and harvested as described above,
and seeding solutions weremade in DMEM to reach anOD600 of
0.1. Old medium was removed from 3T3 cells followed by
addition of 100 μL of seeding solution. The cocultures were
then stored in a box with damp paper towels at 37 C overnight.
The cocultures were washed with PB saline three times before
sensing to remove planktonic bacteria and nonadherent 3T3
cells.
Sensing of BiofilmFibroblast Cell Cocultures. The sensor was
composed as described earlier and was made fresh and incu-
bated in the dark for 15 min before sensing. A 150 μL portion of
the sensing solution was added into each well containing a
biofilm and then incubated for 5min. The fluorescence recovery
was monitored using a Molecular Devices Spectramax M2 plate
reader (see Table S6 for the detailed results).
LDA Performance. Discrimination analysis was performed
using SYSTAT (version 12.0). For biofilm sensing in the micro-
plate, the raw data contained a matrix of 6 (replicates)  6
(biofilms)  3 (channels). The coculture studies generated a
matrix of 6 (replicates)  3 (biofilms plus 3T3 cells alone)  3
(channels). All raw data were subjected to LDA to differentiate
the fluorescence response of the multichannel system against
different biofilm targets. The analysis maximized the ratio of
between-class variance to within-class variance in both data
sets, thereby enabling maximal separation. The matrixes were
transformed to canonical factors that were linear combinations
of the response patterns. The canonical factors contain a
different percentage of the variation, and the first two were
plotted in Figure 3B and Figure 4B.
The Blind Test. For identification of the unknown samples,
we chose seeding solutions of interest and assigned them a
random number. These seeding solutions were used to form
biofilms and tested with the multichannel sensor. The aver-
age response of three data points was used to represent
a single unknown sample. During LDA, the Mahalanobis
distance of the unknown case, which is the distance of the
new case to the centroid of respective groups generated
through the training set, was calculated. Then the unknown
case was classified to the group with the shortest Mahalano-
bis distance.
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